| Description |
1. Benchmark your progress against 15+ preclinical and clinical developments including Prosensa, Genta, Noxxon, Giuliani, Santaris, Regulus, DNA Therapeutics, Geron, Silence Therapeutics and more...
2. Improve the delivery of your products - benefit from a critical review of the current delivery systems from Alnylam's Muthiah Manoharan and UCL's Andy Miller - what have we learnt and what challenges await?
3. Discover the latest scientific findings and where this field is heading: gene silencing and activation; cell-penetrating peptides; riboswitchs; unlocked and lock nuceic acid
4. New Chemistries for Oligos and Peptides: Latest research projects from Merck, Francoise Debart at CNRS and Prof Albericio.
5. Improve product characterisation, optimise CMC for complex delivery systems and hear the latest regulatory updates from regulators and industry alike
|
|
